JCheemaMD Profile Banner
Josh Cheema, MD, MSCI, MSAI Profile
Josh Cheema, MD, MSCI, MSAI

@JCheemaMD

Followers
1K
Following
1K
Media
57
Statuses
955

❤️ Advanced HF & Tx @NMCardioVasc l HCM Doc | Using AI/ML advance patient care

Chicago, IL
Joined January 2018
Don't wanna be here? Send us removal request.
@JCheemaMD
Josh Cheema, MD, MSCI, MSAI
1 year
Out now in @JACCJournals, see our State-Of-The-Art review summarizing the latest evidence for and against IV iron in HF! 💉❤️ #HeartFailure #MedTwitter #IronTherapy @ArdehaliHossein https://t.co/ZRz8KRTqgY
Tweet card summary image
jacc.org
1
3
16
@NMCardioVasc
NM Cardiovascular
1 month
"Too much detail without guidance risks overwhelming people with information that isn’t clinically actionable." Baljash S. Cheema, MD (@JCheemaMD), provides thought leadership on both the benefits and potential risks associated with the DEXA scan and which patients this may help.
0
1
1
@JCardFail
Journal of Cardiac Failure
6 months
🖥️AI can play a key role in prev, early detection & treatment of HF, driven by advancements like multimodal LLMs. But challenges like data privacy, system integration, clinician trust & fairness/bias warrant further study. Read the latest Review: https://t.co/gArn5t02tJ
0
16
26
@CatGaoHow
Cathy Gao-Howard, MD MS
1 year
So honored and grateful for this! Thanks to all the mentors and team members who have supported me. 💖 Looking forward to exciting new work together with @IAIM_NU @IPHAM_CHIP @NM_Lung @NUFeinbergMed and many others!
9
8
62
@NMCardioVasc
NM Cardiovascular
1 year
In this article, medical experts including Baljash Cheema, MD (@JCheemaMD), discuss how #ArtificialIntelligence can affect decisions in #PatientCare, using a real-life case of a patient with advanced #HeartFailure as an example. They highlight the strengths and challenges of the
0
3
8
@NU_IntMed
NU Internal Medicine
1 year
Please help us #congratulate @AkhilNarangMD for being promoted to Associate Professor of Medicine in the division of Cardiology @NMCardioVasc ! #congratulations #departmentofmedicine #nmim
11
11
57
@NilayShahMDMPH
Nilay Shah
1 year
Do US Asians get equitable MI quality of care? In @AHAScience GWTG of >700 US hospitals, Door-to-balloon time <90 mins less likely in Indian men, Filipina women vs. White OMT for MI less likely in Korean men vs White @CircOutcomes: https://t.co/snAij7CUE4
3
23
57
@QuentinYoumans
Quentin Youmans, MD, MSc, FACC, FHFSA
1 year
Enjoyed a great day in the #cathlab this week with our new fellows tackling some complex cases! One thing’s for sure, @NMCardioVasc is a great place to train for #AdvHFTx Cardiology training with the perfect mix of pt complexity, teaching and autonomy all in the 💜 of #Chicago!
0
13
63
@SarahChuzi
Sarah Chuzi, MD, MSc
1 year
⭐️Our piece (w/ Sarah Godfrey & Katie Manning) on How to be a Palliative Cardiologist is out in @JCardFail ⭐️ Here, we describe unique training pathways & career phenotypes for HF 🧑🏾‍⚕️ who want to cultivate a niche in pall care. 📣Trainees- it’s possible & extremely rewarding!
2
17
48
@JCheemaMD
Josh Cheema, MD, MSCI, MSAI
1 year
Not enough time to read our review on IV iron in HF? See this expert summary of the paper, narrated by the one and only Dr. Valentin Fuster. @JACCJournals https://t.co/lL2mBK15Kt
0
2
6
@JCheemaMD
Josh Cheema, MD, MSCI, MSAI
1 year
0
1
1
@Nchatterjeemd
Neal Chatterjee
1 year
Delighted to share our work predicting cardiac arrest in the general population using machine learning and electronic health records. Grateful to @CircAHA for the platform. A years-long interdisciplinary team effort - more to come! https://t.co/x4wKIbE61Y
8
21
75
@JCheemaMD
Josh Cheema, MD, MSCI, MSAI
1 year
Now out in JACC Advances, our viewpoint on AI within HF and how the future may look with the help of multimodality large language models @JayPandit https://t.co/CzrsM2hSMU
0
3
9
@NMCardioVasc
NM Cardiovascular
2 years
Join Northwestern Medicine scientists at ACC.24 for poster session, “Timeline Of The Development Of Cardiovascular Adverse Events Following Treatment With Chimeric Antigen Receptor T Cell Therapies.” @ACCinTouch #ACC24 #NMatACC. See the full schedule here: https://t.co/yaahN8BLs4
0
1
7
@NMCardioVasc
NM Cardiovascular
2 years
At ACC.24, check out Akhil Narang, MD (@AkhilNarangMD) , for his session, “Planning For Your Procedure: The Value of Multimodality Imaging.” @ACCinTouch #ACC24 #NMatACC. See the full schedule here: https://t.co/yaahN8BLs4
0
2
12
@NMCardioVasc
NM Cardiovascular
2 years
Join Robert O. Bonow, MD, at ACC.24 for his session, “Hungry Heart: How Can Clinical Guidance Keep Pace With the Speed of Valve Therapies?” @ACCinTouch #ACC24 #NMatACC See full schedule here: https://t.co/yaahN8BLs4
0
1
6
@NMCardioVasc
NM Cardiovascular
2 years
At ACC.24, join Sarah E. Chuzi, MD (@SarahChuzi), for her panel session, “Futility Versus Blind Heroism: Where Do We Draw the Line in Cardiogenic Shock and Cardiac Arrest?” @ACCinTouch #ACC24 #NMatACC. See the full schedule here: https://t.co/yaahN8BdCw
0
2
13
@NMCardioVasc
NM Cardiovascular
2 years
At ACC.24, check out Paul C. Cremer, MD, for his panel session, “Multi-Modality Imaging in Patients With Recurrent Pericarditis.” @ACCinTouch #ACC24 #NMatACC. See the full schedule here: https://t.co/yaahN8BdCw
0
1
6
@JCheemaMD
Josh Cheema, MD, MSCI, MSAI
2 years
Thanks for the support team!!!
@NMCardioVasc
NM Cardiovascular
2 years
Spotted: Sarah Chuzi, MD (@SarahChuzi), and Quentin R. Youmans, MD, MSc (@QuentinYoumans) learning from Baljash Cheema, MD, during his presentation, “New Frontiers in Hypertrophic Cardiomyopathy. Revolutionizing HCM Care: The Role of Cardiac Myosin Inhibition.” #ACC24
0
1
9